Log In
Print this Print this

PredictMDx for Glioblastoma

Also known as: PredictMDx for Brain

  Manage Alerts
Collapse Summary General Information
Company MDxHealth S.A.
DescriptionAssay for determining the methylation status of the O-6-methylguanine DNA methyltransferase (MGMT) gene
Molecular Target O6-alkylguanine alkyltransferase (MGMT)
Mechanism of ActionDiagnostic
Therapeutic ModalityDiagnostics
Latest Stage of DevelopmentPivotal
Standard IndicationCancer, Diagnostic
Indication DetailsIdentify glioblastoma patients most likely to respond to therapy; Identify patients with glioblastoma multiforme (GBM) who are more likely to respond to treatment with temozolomide
Regulatory Designation


Teva Pharmaceutical Industries Ltd.

 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today